During the past 12 months, ImmuCell's average Revenue per Share Growth Rate was 44.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 2.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 3.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -0.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of ImmuCell was 34.50% per year. The lowest was -19.40% per year. And the median was 3.55% per year.
Competitive Comparison of ImmuCell's 3-Year Revenue Growth Rate
For the Biotechnology subindustry, ImmuCell's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ImmuCell's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ImmuCell's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where ImmuCell's 3-Year Revenue Growth Rate falls into.
ImmuCell 3-Year Revenue Growth Rate Calculation
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
ImmuCell 3-Year Revenue Growth Rate Related Terms
Thank you for viewing the detailed overview of ImmuCell's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ICCC has been successfully added to your